Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TargeGen brings in $30mm with its Series C round

Executive Summary

TargeGen (focused on developing cardiovascular, ophthalmic, and cancer therapeutics) has raised $30mm with its oversubscribed Series C venture round. Lead (and new) investor BB Biotech Ventures was joined by H&Q Capital Management and current backers Forward Ventures, Enterprise Partners, William Blair Capital Partners, Chicago Growth Partners, CDP Capital-Technology Ventures, VantagePoint Venture Partners, China Development Industrial Bank, and AM Pappas.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies